Related Experiment Video

Updated: Feb 4, 2026

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

14.4K

The use of stem cells in ischemic heart disease treatment

Radoslaw Litwinowicz1, Bogusław Kapelak1, Jerzy Sadowski1

  • 1Department of Cardiovascular Surgery and Transplantology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland.

Kardiochirurgia I Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery
|October 13, 2018
PubMed

Insights

Cell-based therapies offer an alternative for ischemic heart disease when revascularization isn't possible. Direct stem cell implantation in the heart shows promise for improving blood flow and tissue repair.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Therapy

Background:

  • Ischemic heart disease (IHD) is a leading global cause of mortality and morbidity.
  • Direct revascularization is not a viable option for all IHD patients.
  • Cell-based therapies are being explored to enhance neovascularization and endothelial repair in the heart.

Purpose of the Study:

  • To review the potential of cell-based therapies for treating ischemic heart disease.
  • To discuss various stem cell types and delivery methods for myocardial regeneration.
  • To highlight direct stem cell implantation as a promising approach for IHD.

Main Methods:

  • Review of existing literature on stem cell types investigated for IHD.
  • Analysis of different delivery methods for cell-based therapies.
  • Evaluation of factors influencing the success of stem cell treatments.

Main Results:

  • Multiple stem cell populations, including mesenchymal stromal cells (MSCs) and endothelial progenitor cells, have been studied.
  • No definitive consensus exists on the optimal cell type for clinical application.
  • Direct implantation into the ischemic myocardium is considered an attractive strategy due to poor coronary artery systems.

Conclusions:

  • Cell-based therapies hold significant potential as an alternative treatment for ischemic heart disease.
  • Further research is needed to determine the most effective stem cell type and delivery method.
  • Direct stem cell delivery to the ischemic heart muscle presents a promising therapeutic avenue.

Keywords:
ischemic heart diseaseregenerative medicinestem cells

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K
Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

7.2K

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
952
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
519
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K